SCHEMBL21936388

SCHEMBL21936388

O=C(NC1CCCCC1)c1cc(Cc2ccc(-n3cccn3)cc2)c2occc2n1

nearest known ligand 0.58

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 17/20 0.52
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30428011 0.89 CHRM1 (0.67) CHRM1
SCHEMBL21873485 0.89 CHRM1 (0.67) CHRM1
SCHEMBL21873386 0.85 CHRM1 (0.64) CHRM1
SCHEMBL31668938 0.85 CHRM1 (0.64) CHRM1
SCHEMBL31668963 0.84 CHRM1 (0.72) CHRM1
SCHEMBL21873399 0.84 CHRM1 (0.72) CHRM1
SCHEMBL23673082 0.83 CHRM1 (0.52) CHRM1
SCHEMBL21873503 0.83 MPO (0.44) CHRM1
SCHEMBL30428202 0.83 MPO (0.44) CHRM1
SCHEMBL21235339 0.82 CHRM1 (0.61) CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643718-B1 HETEROCYCLIC COMPOUND AND ITS USE AS POSITIVE ALLOSTERIC MODULATOR OF THE CHOLINERGIC MUSCARINIC M1 RECEPTOR. TAKEDA PHARMACEUTICALS CO (JP) 2023-07-26 — — EP disclosed
EP-3643718-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2020-04-29 — — EP disclosed
Send feedback